U-Fiber Leukoencephalopathy Due to a Novel Mutation in the TACO1 Gene
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 29, 2020
- Accepted in final form January 12, 2021
- First Published March 9, 2021.
Author Disclosures
- Giacomo Sferruzza, MD (sferruzza.giacomo{at}hsr.it),
- Andrea Del Bondio, PhD (delbondio.andrea{at}hsr.it),
- Andrea Citterio, PhD (andrea.citterio{at}bp.lnf.it),
- Paolo Vezzulli, MD (vezzulli.paolo{at}hsr.it),
- Simone Guerrieri, MD (guerrieri.simone{at}hsr.it),
- Marta Radaelli, MD, PhD (mradaelli{at}asst-pg23.it),
- Filippo Martinelli Boneschi, MD, PhD (filippo.martinelli{at}unimi.it),
- Massimo Filippi, MD, PhD (filippi.massimo{at}hsr.it),
- Francesca Maltecca, PhD (maltecca.francesca{at}hsr.it),
- Maria Teresa Bassi, PhD (mariateresa.bassi{at}lanostrafamiglia.it) and
- Marina Scarlato, MD, PhD
- Giacomo Sferruzza, MD (sferruzza.giacomo{at}hsr.it),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andrea Del Bondio, PhD (delbondio.andrea{at}hsr.it),
NONE
NONE
Travel bursary to attend International Ataxia Research Conference 2019 (Washington DC, November 2019), wire transfer
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
2-years research fellowship from Fondazione Centro San Raffaele
NONE
NONE
NONE
NONE
NONE
NONE
- Andrea Citterio, PhD (andrea.citterio{at}bp.lnf.it),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Paolo Vezzulli, MD (vezzulli.paolo{at}hsr.it),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Simone Guerrieri, MD (guerrieri.simone{at}hsr.it),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marta Radaelli, MD, PhD (mradaelli{at}asst-pg23.it),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Filippo Martinelli Boneschi, MD, PhD (filippo.martinelli{at}unimi.it),
Sanofi Genzyme, Merck-Serono, Roche Teva Pharmaceutical Industries,
NONE
Roche Teva Pharmaceutical Industries, Merck-Serono, Biogen Idec
Almirall
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Merck-Serono
Italian Ministry of Health
European Union
Fondazione Italiana Sclerosi Multipla and Fondazione Cariplo
NONE
NONE
NONE
NONE
NONE
NONE
- Massimo Filippi, MD, PhD (filippi.massimo{at}hsr.it),
NONE
NONE
Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries
Editor-in-Chief (2012-present), Journal of Neurology; Associate Editor, Neurological Sciences (2016-present); Associate Editor, Human Brain Mapping (since 2020)
NONE
NONE
NONE
Biogen Idec, Merck-Serono, Novartis
Bayer, Biogen Idec, Merck-Serono, Novartis, Roche, Sanofi Genzyme, Takeda, and Teva Pharmaceutical Industries
NONE
NONE
1) Commercial entity: Bayer 2) Commercial entity: Biogen-Idec 3) Commercial entity: Merck-Serono 4) Commercial entity: Novartis 5) Commercial entity: Roche 6) Commercial entity: Teva Pharmaceutical Industries
1) Italian Ministry of Health; grant number: GR-2013- 02357415; role: co-investigator; duration: September 2016-December 2020 2) Italian Ministry of Health; grant number: RF-2018- 12366746; role: PI; duration: 15/06/2020 Â 14/06/2023
NONE
1) Fondazione Italiana Sclerosi Multipla (FISM) 2) ARiSLA (Fondazione Italiana di Ricerca per la SLA)
NONE
NONE
NONE
NONE
NONE
NONE
- Francesca Maltecca, PhD (maltecca.francesca{at}hsr.it),
NONE
NONE
Travel expenses as invited speaker for ARCA GLOBAL meeting, Denver (US), March 2020. Wire transfer to the travel agency.
NONE
NONE
Maltecca F, Casari G. In vivo detection of oxidized proteins: a practical approach to tissue-derived mitochondria. Methods Mol Biol. 2010;648:257-67. doi: 10.1007/978-1-60761-756-3_17. Springer Nature.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Ataxia Foundation, Minneapolis, US, 03/01/2020. ÂTargeting altered proteostasis in cellular and mouse models of AFG3L2-related cerebellar ataxias (SCA28 and SPAX5)Â. Role: PI Ataxia Charlevoix-Saguenay Foundation, Montréal, CA 10/01/2019. ÂTargeting deregulated calcium homeostasis as potential therapeutic option for ARSACSÂ. Role: PI
NONE
NONE
NONE
NONE
NONE
NONE
- Maria Teresa Bassi, PhD (mariateresa.bassi{at}lanostrafamiglia.it) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Marina Scarlato, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (G.S., S.G., M.F., M.S.), and Mitochondrial Dysfunctions in Neurodegeneration Unit (A.D.B., F.M.), Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan; Laboratory of Molecular Biology (A.C., M.T.B.), Scientific Institute IRCCS E. Medea, Bosisio Parini, Lecco; Department of Neuroradiology (P.V.), IRCCS San Raffaele Scientific Institute, Milan; Department of Neurology (M.R.), Papa Giovanni XXIII, Bergamo; Dino Ferrari Centre (F.M.B.), Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan; and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (F.M.B.), Neurology Unit and Multiple Sclerosis Center, Milan, Italy.
- Correspondence
Dr. Scarlato scarlato.marina{at}hsr.it
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
Spinal muscular atrophy-like picture, cardiomyopathy, and cytochrome c oxidase deficiencyM.E. Rubio-Gozalbo, J.A. M. Smeitink, W. Ruitenbeek et al.Neurology, January 01, 1999 -
Article
SURF1 deficiency causes demyelinating Charcot-Marie-Tooth diseaseAndoni Echaniz-Laguna, Daniele Ghezzi, Maïté Chassagne et al.Neurology, September 11, 2013 -
Article
IBA57 mutations abrogate iron-sulfur cluster assembly leading to cavitating leukoencephalopathyAkihiko Ishiyama, Chika Sakai, Yuichi Matsushima et al.Neurology: Genetics, September 08, 2017 -
Brief Communications
A new mtDNA mutation associated with a progressive encephalopathy and cytochrome c oxidase deficiencyG. Silvestri, T. Mongini, F. Odoardi et al.Neurology, April 25, 2000